Nadia D. Morgan

Scleroderma Mimickers

L. Hummers, Nadia D. Morgan, 2016, Current Treatment Options in Rheumatology.

HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry

Ami A. Shah, C. Rotimi, A. Adeyemo, 2019, Proceedings of the National Academy of Sciences.

Suspected hydroxychloroquine-associated QT-interval prolongation in a patient with systemic lupus erythematosus.

Sheetal Patel, Olga Dvorkina, Nadia D. Morgan, 2013, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.

Ami A. Shah, J. Poole, F. Mendoza, 2021, Best practice & research. Clinical rheumatology.

Systemic lupus erythematosus associated with type 4 renal tubular acidosis: a case report and review of the literature

O. Lenz, M. Garcia-Buitrago, Nadia D. Morgan, 2011, Journal of medical case reports.

Clinical and serological features of systemic sclerosis in a multicenter African American cohort

Ami A. Shah, M. Mayes, E. Remmers, 2017, Medicine.

Brief Report: Whole‐Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans

Ami A. Shah, C. Rotimi, A. Adeyemo, 2018, Arthritis & rheumatology.